Macular degeneration is a condition characterized by loss of central vision caused by degradation or breakdown of retinal macula. While typically it affects only one eye at once, macular degeneration

Macular degeneration can result in loss of central vision which is essential for reading, driving and other daily tasks. To delay its onset or prevent its worsening it can be

The macula is the central region of retina that is responsible for clear central and forward vision. If it becomes blurry or disoriented it could even become dark enough to

A novel gene-based therapy targets the protein responsible for macular degeneration, improving patients’ vision with advanced AMD. Genentech has developed Susvimo, an anti-VEGF implant with refillable cartridges designed to replace

Age related macular degeneration (AMD) is an eye condition that leads to central vision loss and may be brought on by genetics and smoking, among other things. However, there are

Under dry AMD, drusen deposits form under the retina and gradually obscure vision. Patients may still maintain reading vision and can continue their lives as before. Wet AMD occurs when

SYFOVRE blocks C3, a protein from the complement system that contributes to abnormal blood vessel formation in wet AMD. This treatment may preserve vision in people suffering from geographic atrophy

Neovascular (wet) age-related macular degeneration accounts for most vision loss among people aged 60 or above, caused when abnormal blood vessels form and leak within the macula, leading to blurred

Doctors across America have been saving sight using an injectable drug that slows the formation of new blood vessels under the retina, helping people suffering from wet age-related macular degeneration